Discuss This Drug

molnupiravir

CHEBI:CHEBI_180653

Definition

A nucleoside analogue that is N(4)-hydroxycytidine in which the 5'-hydroxy group is replaced by a (2-methylpropanoyl)oxy group. It is the prodrug of the active antiviral ribonucleoside analog N(4)-hydroxycytidine (EIDD-1931), has activity against a number of RNA viruses including SARS-CoV-2, MERS-CoV, and seasonal and pandemic influenza viruses. It is currently in phase III trials for the treatment of patients with COVID-19.

Chemical Information

Molecular Formula
C13H19N3O7
Molecular Mass
329.309
Charge
0
SMILES
CC(C)C(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(NC1=O)=NO
InChI
InChI=1S/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18,21H,5H2,1-2H3,(H,14,15,20)/t7-,9-,10-,11-/m1/s1
InChIKey
HTNPEHXGEKVIHG-QCNRFFRDSA-N

Alternative Names

  • {(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl]tetrahydrofuran-2-yl}methyl 2-methylpropanoate
  • beta-D-N(4)-hydroxycytidine-5'-isopropyl ester
  • EIDD 1931 5'-isopropylester
  • EIDD 2801
  • EIDD-2801
  • MK-4482
  • molnupiravir
  • molnupiravirum
  • N-hydroxy-5'-O-(2-methylpropanoyl)-3,4-dihydrocytidine
  • N(4)-hydroxycytidine 5'-isopropylester

Treatment Applications

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
2587901
oboInOwl#hasDbXref
Wikipedia:Molnupiravir
core#notation
CHEBI:180653

Additional References

Wikipedia:Molnupiravir

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
2587901
oboInOwl#hasDbXref
Wikipedia:Molnupiravir
oboInOwl#id
CHEBI:180653
generic_name
Molnupiravir
product_type
BULK INGREDIENT
listing_expiration_date
20241231
dosage_form
CAPSULE
marketing_start_date
20211223
marketing_category
BULK INGREDIENT
labeler_name
MSD International GmbH (Puerto Rico Branch) LLC
product_ndc
62331-063
brand_name
LAGEVRIO
brand_name_base
LAGEVRIO
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_50266
chebi#has_functional_parent
http://purl.obolibrary.org/obo/CHEBI_180654
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
core#notation
CHEBI:180653
rxcui
2603740
route
ORAL
active_ingredient_strength
20 kg/20kg
package_marketing_start_date
06-DEC-21
manufacturer_name
A-S Medication Solutions
spl_id
f41380dd-364a-4a39-94ad-b1ca1afbb86f
active_ingredient_name
MOLNUPIRAVIR
package_ndc
62331-063-31
package_description
30 kg in 1 DRUM (62331-063-31)
unii
YA84KI1VEW
spl_set_id
05727725-6bd1-48de-a65a-662882b07a2d
upc
0300065055060
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#range
https://w3id.org/def/predibionto#has_drug_108952
has_treatment
http://purl.obolibrary.org/obo/DOID_0081014
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect10544
owl#annotatedSource
t141546
owl#someValuesFrom
t3839710